NDUFB2 and non-small cell lung carcinoma: Recently, a study indicated that circNDUFB2, derived from NADH: ubiquinone oxidoreductase subunit B2, is frequently downregulated in non-small cell lung cancer (NSCLC), and negatively correlated with the malignant characteristics of NSCLC.